M2 and M3 muscarinic receptors are involved in enteric nerve-mediated contraction of the mouse ileum: Findings obtained with muscarinic-receptor knockout mouse.
The involvement of muscarinic receptors in neurogenic responses of the ileum was studied in wild-type and muscarinic-receptor (M-receptor) knockout (KO) mice. Electrical field stimulation to the wild-type mouse ileum induced a biphasic response, a phasic and sustained contraction that was abolished by tetrodotoxin. The sustained contraction was prolonged for an extended period after the termination of electrical field stimulation. The phasic contraction was completely inhibited by atropine. In contrast, the sustained contraction was enhanced by atropine. Ileal strips prepared from M2-receptor KO mice exhibited a phasic contraction similar to that seen in wild-type mice and a sustained contraction that was larger than that in wild-type mice. In M3-receptor KO mice, the phasic contraction was smaller than that observed in wild-type mice. Acetylcholine exogenously administrated induced concentration-dependent contractions in strips isolated from wild-type, M2- and M3-receptor KO mice. However, contractions in M3-receptor KO mice shifted to the right. The sustained contraction was inhibited by capsaicin and neurokinin NK2 receptor antagonist, suggesting that it is mediated by substance P (SP). SP-induced contraction of M2-receptor KO mice did not differ from that of wild-type mice. SP immunoreactivity was located in enteric neurons, colocalized with M2 receptor immunoreactivity. These results suggest that atropine-sensitive phasic contraction is mainly mediated via the M3 receptor, and SP-mediated sustained contraction is negatively regulated by the M2 receptor at a presynaptic level.
Takeuchi
Tadayoshi
T
Department of Veterinary Pharmacology, Graduate School of Life and Environmental Sciences, Osaka Prefecture University, Sakai Osaka 599-8531, Japan. takeuchi@vet.osakafu-u.ac.jp
Tanaka
Keisuke
K
Nakajima
Hidemitsu
H
Matsui
Minoru
M
Azuma
Yasu-Taka
YT
D000109:Acetylcholine / Q000494:pharmacology; D000818:Animals; D001285:Atropine / Q000494:pharmacology; D002211:Capsaicin / Q000494:pharmacology; D017615:Enteric Nervous System / Q000187:drug effects / Q000502:physiology*; D007082:Ileum / Q000294:innervation* / Q000502:physiology; D051379:Mice; D018345:Mice, Knockout; D009130:Muscle, Smooth / Q000294:innervation*; D043585:Receptor, Muscarinic M2 / Q000172:deficiency / Q000502:physiology*; D043587:Receptor, Muscarinic M3 / Q000172:deficiency / Q000502:physiology*; D043588:Receptor, Muscarinic M4 / Q000172:deficiency / Q000502:physiology*; D013373:Substance P / Q000494:pharmacology
D043585:Receptor, Muscarinic M2; D043587:Receptor, Muscarinic M3; D043588:Receptor, Muscarinic M4; D013373:Substance P; D001285:Atropine; D000109:Acetylcholine; D002211:Capsaicin